title: Propranolol treatment of paruresis (psychogenic urinary retention): a brief case report.
abstract: Propranolol, a nonselective beta-blocker, was administered to a client with paruresis (psychogenic urinary retention) following a novel in vivo exposure treatment. The client did not report a significant increase in his ability to urinate in public facilities during subsequent exposures. Rationale for including propranolol as an adjunct to exposure therapy of paruresis is discussed.
authors.affiliation: Department of Psychology, University of Portland, Oregon 97203.
authors.forename: G D
authors.initials: GD
authors.lastname: Zgourides
authors.forename: R
authors.initials: R
authors.lastname: Warren
mesh_terms: D000328:Adult; D001143:Arousal / Q000187:drug effects*; D003131:Combined Modality Therapy; D003887:Desensitization, Psychologic / Q000379:methods*; D006801:Humans; D008297:Male; D011433:Propranolol / Q000627:therapeutic use*; D012931:Social Environment; D016055:Urinary Retention / Q000188:drug therapy* / Q000523:psychology
chemical_list: D011433:Propranolol